 Warfarin
"Warfarin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.
| Descriptor ID |
D014859
|
| MeSH Number(s) |
D03.438.150.446.520.914 D03.830.219.446.520.914
|
| Concept/Terms |
Warfarin- Warfarin
- 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Coumadine- Coumadine
- Bailly Brand of Warfarin Sodium
Warfant- Warfant
- Antigen Brand of Warfarin Sodium
Coumadin- Coumadin
- Goldshield Brand of Warfarin Sodium
- Marevan
- Boots Brand of Warfarin Sodium
- Bristol-Myers Squibb Brand of Warfarin Sodium
Aldocumar- Aldocumar
- Aldo Brand of Warfarin Sodium
Tedicumar- Tedicumar
- Estedi Brand of Warfarin Sodium
|
Below are MeSH descriptors whose meaning is more general than "Warfarin".
Below are MeSH descriptors whose meaning is more specific than "Warfarin".
This graph shows the total number of publications written about "Warfarin" by people in this website by year, and whether "Warfarin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 0 | 1 | 1 | | 1991 | 1 | 0 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 | | 1995 | 2 | 2 | 4 | | 1997 | 0 | 1 | 1 | | 1999 | 3 | 0 | 3 | | 2000 | 1 | 4 | 5 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 2 | 3 | | 2003 | 2 | 1 | 3 | | 2004 | 1 | 2 | 3 | | 2005 | 0 | 4 | 4 | | 2006 | 2 | 2 | 4 | | 2007 | 2 | 0 | 2 | | 2009 | 2 | 2 | 4 | | 2010 | 2 | 1 | 3 | | 2011 | 1 | 1 | 2 | | 2012 | 1 | 2 | 3 | | 2013 | 6 | 1 | 7 | | 2014 | 3 | 1 | 4 | | 2015 | 2 | 1 | 3 | | 2016 | 0 | 1 | 1 | | 2017 | 3 | 0 | 3 | | 2018 | 3 | 2 | 5 | | 2019 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Warfarin" by people in Profiles.
-
Beaser AD, Cifu AS. Management of Patients With Atrial Fibrillation. JAMA. 2019 Mar 19; 321(11):1100-1101.
-
Lee YM, Danahey K, Knoebel RW, Ratain MJ, Meltzer DO, O'Donnell PH. Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing. Pharmacogenet Genomics. 2019 02; 29(2):23-30.
-
Wool GD. Benefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management: An ACLPS Critical Review. Am J Clin Pathol. 2019 01 01; 151(1):1-17.
-
De T, Alarcon C, Hernandez W, Liko I, Cavallari LH, Duarte JD, Perera MA. Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent. JAMA. 2018 10 23; 320(16):1670-1677.
-
Bawa H, Weick JW, Dirschl DR, Luu HH. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty. J Am Acad Orthop Surg. 2018 Oct 01; 26(19):698-705.
-
Patel P, Nigam N, Sengupta N. Resumption of Warfarin After Hospitalization for Lower Gastrointestinal Bleeding and Mortality Benefits. J Clin Gastroenterol. 2018 07; 52(6):545-550.
-
Anderson I, Cifu AS. Management of Bleeding in Patients Taking Oral Anticoagulants. JAMA. 2018 May 15; 319(19):2032-2033.
-
Edelstein AI, Terzaghi C, Nudelman B, Qin C, Kwasny M, Manning DW. Early Response to Warfarin Initiation and the Risk of Venous Thromboembolism After Total Joint Arthroplasty. J Am Acad Orthop Surg. 2018 Feb 15; 26(4):e90-e97.
-
Enter DH, Zaki AL, Marsh M, Cool N, Kruse J, Li Z, Andrei AC, Iddriss A, McCarthy PM, Malaisrie SC, Anderson A, Rich JD, Pham DT. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation. Pharmacotherapy. 2017 Oct; 37(10):1215-1220.
-
Offman E, Davidson M, Nilsson C. No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers. Am J Cardiovasc Drugs. 2017 Jun; 17(3):251-260.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|